ParaZero Technologies Ltd., an aerospace defense company trading on NASDAQ under the symbol PRZO, has appointed Bat-Sheva Noy as its new Vice President of Global Sales. The company, which focuses on smart autonomous solutions for both manned and unmanned aerial systems, announced the appointment as part of its strategy to strengthen its commercial operations worldwide.
Noy brings over two decades of commercial and leadership experience to ParaZero, most recently serving as Business Unit Lead for Rare Diseases at Pfizer Israel from 2020 to 2025. In that role, she was responsible for strategic planning, team development, and overall business performance. ParaZero stated that her background in strategic planning, market access, and cross-functional leadership will be instrumental in supporting the company's efforts to expand its global commercial presence.
This appointment comes at a critical time for the drone safety and aerospace sector, which has seen significant growth as commercial, industrial, and governmental operations increasingly rely on unmanned aerial systems. ParaZero is recognized as a leader in advanced drone technologies, with a product portfolio that includes several key safety systems. The company's SafeAir system provides an autonomous parachute recovery solution designed for aerial safety and regulatory compliance, while DefendAir offers a counter-UAS net-launching platform for protection against hostile drones in both battlefield and urban environments. Additionally, ParaZero's DropAir system enables precision aerial delivery operations.
The strategic importance of this appointment extends beyond ParaZero's immediate corporate structure. As drone technology becomes more integrated into various sectors including logistics, defense, and emergency services, the need for reliable safety systems has become increasingly critical. Noy's experience in the highly regulated pharmaceutical industry, particularly in market access and strategic planning, could provide valuable insights for navigating the evolving regulatory landscape surrounding drone operations globally.
ParaZero's mission to redefine aerial operations with intelligent, mission-ready systems that enhance safety, scalability, and security aligns with broader industry trends toward more sophisticated unmanned aerial capabilities. The company's focus on both safety systems like SafeAir and defensive technologies like DefendAir positions it at the intersection of commercial drone expansion and national security concerns. More information about ParaZero Technologies is available through the company's newsroom at https://ibn.fm/PRZO.
This leadership appointment represents a strategic move by ParaZero to leverage commercial expertise from outside the traditional aerospace sector. Noy's pharmaceutical background suggests the company may be adopting approaches from industries with established global commercialization frameworks and complex regulatory environments. As drone technology continues to evolve and expand into new applications, the commercial strategies employed by companies like ParaZero will play a significant role in determining how quickly these technologies are adopted across different markets and regions.
